Mirae Asset Global ETFs Holdings’s ClearPoint Neuro CLPT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Buy	12,981 +469	+4%	+$5.86K	﹤0.01%	2408
2026 Q1	$114K	Buy	12,512 +306	+3%	+$3.86K	﹤0.01%	2606
2025 Q4	$167K	Sell	12,206 -7	-0.1%	-$130	﹤0.01%	2433
2025 Q3	$266K	Sell	12,213 -2,050	-14%	-$24.1K	﹤0.01%	2169
2025 Q2	$170K	Buy	+14,263	New	+$179K	﹤0.01%	2364
2024 Q3	–	Sell	-11,389	Closed	-$61.4K	–	3094
2024 Q2	$61.4K	Buy	+11,389	New	+$65.9K	﹤0.01%	2737

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CFM

Compass Financial Management Tampa, Florida $829M AUM

Mirae Asset Global ETFs Holdings's CLPT Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its ClearPoint Neuro (CLPT) stake by 3.7% in Q2 2026, buying an estimated $5.86K and bringing the position to 12,981 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

Mirae Asset Global ETFs Holdings first reported a position in CLPT in Q2 2024 and has held it in 6 quarters since. The position peaked at $266K in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

Mirae Asset Global ETFs Holdings held 12,981 shares of ClearPoint Neuro worth $232K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 469 ClearPoint Neuro shares in Q2 2026, an estimated $5.86K.
ClearPoint Neuro made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2408 holding.
Mirae Asset Global ETFs Holdings first reported a position in ClearPoint Neuro in Q2 2024 and has held it in 6 quarters since.
Mirae Asset Global ETFs Holdings's ClearPoint Neuro position peaked at $266K in Q3 2025.
129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.